Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Dec 08, 2009 10:25pm
90 Views
Post# 16567194

22 days left ... no "bad" news...

22 days left ... no "bad" news...
Easy math

0,25 cash valuation
0,40 asset valuation (Caprion at book value not market value)

0,10 tech value.


Stock value is undervalued.

i think curent shareholders is protected from any downside.

We march toward the trial test date.
Trading is irrelevant to trial success, it has always been.


<< Previous
Bullboard Posts
Next >>